These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 25933795)

  • 1. Combined varenicline and naltrexone treatment reduces smoking topography intensity in heavy-drinking smokers.
    Roche DJ; Bujarski S; Hartwell E; Green R; Ray LA
    Pharmacol Biochem Behav; 2015 Jul; 134():92-8. PubMed ID: 25933795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings.
    Ray LA; Courtney KE; Ghahremani DG; Miotto K; Brody A; London ED
    Psychopharmacology (Berl); 2014 Oct; 231(19):3843-53. PubMed ID: 24733235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between negative affect and smoking topography in heavy drinking smokers.
    Green R; Bujarski S; Roche DJ; Ray LA
    Addict Behav; 2016 Oct; 61():53-7. PubMed ID: 27240211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distress Tolerance and Craving for Cigarettes Among Heavy Drinking Smokers.
    Lim AC; Roche DJO; Ray LA
    J Stud Alcohol Drugs; 2018 Nov; 79(6):918-928. PubMed ID: 30573023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findings.
    Ray LA; Courtney KE; Ghahremani DG; Miotto K; Brody A; London ED
    Am J Drug Alcohol Abuse; 2015 Jan; 41(1):35-44. PubMed ID: 24949564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction: A Randomized Clinical Trial.
    Ray LA; Green R; Enders C; Leventhal AM; Grodin EN; Li G; Lim A; Hartwell E; Venegas A; Meredith L; Nieto SJ; Shoptaw S; Ho D; Miotto K
    Am J Psychiatry; 2021 Sep; 178(9):818-828. PubMed ID: 34080890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Double-Blind Randomized Placebo-Controlled Trial of Oral Naltrexone for Heavy-Drinking Smokers Seeking Smoking Cessation Treatment.
    Kahler CW; Cioe PA; Tzilos GK; Spillane NS; Leggio L; Ramsey SE; Brown RA; O'Malley SS
    Alcohol Clin Exp Res; 2017 Jun; 41(6):1201-1211. PubMed ID: 28401564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination Treatment With Varenicline and Nicotine Patch on Smoking Cessation Outcomes in Heavy Drinkers at 26-Week Follow-up.
    Robinson LE; Didier N; Thomas R; Vena A; King A
    J Clin Psychopharmacol; 2024 Jul-Aug 01; 44(4):362-368. PubMed ID: 38752924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination treatment with varenicline and naltrexone reduces World Health Organization risk drinking levels.
    Nieto SJ; Enders CK; Witkiewitz K; O'Malley SS; Ray LA
    Alcohol Clin Exp Res; 2022 Dec; 46(12):2258-2266. PubMed ID: 36515648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Varenicline Alone and in Combination With Low-dose Naltrexone on Alcohol-primed Smoking in Heavy-drinking Tobacco Users: A Preliminary Laboratory Study.
    Roberts W; Shi JM; Tetrault JM; McKee SA
    J Addict Med; 2018; 12(3):227-233. PubMed ID: 29438157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Searching for Personalized Medicine for Binge Drinking Smokers: Smoking Cessation Using Varenicline, Nicotine Patch, or Combination Nicotine Replacement Therapy.
    Kaye JT; Johnson AL; Baker TB; Piper ME; Cook JW
    J Stud Alcohol Drugs; 2020 Jul; 81(4):426-435. PubMed ID: 32800078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone improves quit rates, attenuates smoking urge, and reduces alcohol use in heavy drinking smokers attempting to quit smoking.
    Fridberg DJ; Cao D; Grant JE; King AC
    Alcohol Clin Exp Res; 2014 Oct; 38(10):2622-9. PubMed ID: 25335648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining Varenicline (Chantix) with Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in a Rodent Model of Alcoholism.
    Froehlich JC; Fischer SM; Dilley JE; Nicholson ER; Smith TN; Filosa NJ; Rademacher LC
    Alcohol Clin Exp Res; 2016 Sep; 40(9):1961-70. PubMed ID: 27469281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined varenicline and naltrexone attenuates alcohol cue-elicited activation in heavy drinking smokers.
    Grodin EN; Burnette EM; Green R; Lim AC; Miotto K; Ray LA
    Drug Alcohol Depend; 2021 Aug; 225():108825. PubMed ID: 34175784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of Menstrual Cycle Hormones on Responses to Varenicline and Naltrexone Among Female Heavy Drinking Smokers.
    Green R; Roche DJO; Ray LA
    Alcohol Alcohol; 2022 Sep; 57(5):609-614. PubMed ID: 35470371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Varenicline Combined With Medical Management on Alcohol Use Disorder With Comorbid Cigarette Smoking: A Randomized Clinical Trial.
    O'Malley SS; Zweben A; Fucito LM; Wu R; Piepmeier ME; Ockert DM; Bold KW; Petrakis I; Muvvala S; Jatlow P; Gueorguieva R
    JAMA Psychiatry; 2018 Feb; 75(2):129-138. PubMed ID: 29261824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bupropion and naltrexone for smoking cessation: A double-blind randomized placebo-controlled clinical trial.
    Mooney ME; Schmitz JM; Allen S; Grabowski J; Pentel P; Oliver A; Hatsukami DK
    Clin Pharmacol Ther; 2016 Oct; 100(4):344-52. PubMed ID: 27213949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking topography and abstinence in adult female smokers.
    McClure EA; Saladin ME; Baker NL; Carpenter MJ; Gray KM
    Addict Behav; 2013 Dec; 38(12):2833-6. PubMed ID: 24018226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of smoking abstinence and chain-smoking on puffing topography and diurnal nicotine exposure.
    Kolonen S; Tuomisto J; Puustinen P; Airaksinen MM
    Pharmacol Biochem Behav; 1992 Jun; 42(2):327-32. PubMed ID: 1631188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Combination of Naltrexone + Varenicline Retards the Expression of a Genetic Predisposition Toward High Alcohol Drinking.
    Froehlich JC; Fischer SM; Nicholson ER; Dilley JE; Filosa NJ; Smith TN; Rademacher LC
    Alcohol Clin Exp Res; 2017 Mar; 41(3):644-652. PubMed ID: 28055135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.